|
electroCore Provides Business Update and Select Second Quarter 2021 Financial GuidanceelectroCore reported an operating and business update as well as select unaudited preliminary financial guidance for the second quarter of 2021 |
|
Neovasc Announces New Appointments in Regulatory and Clinical LeadershipNeovasc announced the addition of industry veterans Lisa Becker as VP, Regulatory Affairs, Global Angina Therapies and Sarah Gallagher as VP of Clinical Affairs Research, News & Market Data on Neovasc |
|
Sierra Metals To Release Q2-2021 Consolidated Financial Results On Monday August 9th, 2021Sierra Metals announced it will release Q2-2021 financial results on Monday August 9th, 2021 after Market Close Research, News & Market Data on Sierra Metals |
|
OpRegen® Data Update to Be Featured at 54th Annual Retina Society MeetingLineage Cell Therapeutics announced that updated interim results from a Phase 1/2a study of its lead product candidate, OpRegen, will be featured in a podium presentation at the 54th Annual Scientific Meeting of the Retina Society Research, News & Market Data on Lineage Cell Therapeutics |
Stay up to date. Follow us: